Early growth response 1 (Egr1) is another target gene of miR-150 [153], and knockdown of this target alleviates the diabetes-induced inflammation in mouse mesangial cells by downregulating pro-inflammatory factors (IL-1β, IL-6, and TNF-α) [154,155]. Here, IL6 is linked to diabetes mellitus.